Universal Insurance’s Surge Amid Swings

Robust recent gains meet rising volatility, forcing investors to balance reward and risk

UVE Universal Insurance Holdings, Inc.

In this report

01

Company Profile & Classification

Sector, moat, style, market positioning

P. 2

→

02

Equity Performance & Market Positioning

Returns, risk metrics, smart money positioning

P. 3-4

→

03

Revenue, Earnings & Margin History

Growth trajectory, margins, EPS, cost structure

P. 5-6

→

04

Profitability & Return on Capital

DuPont, ROIC, efficiency, asset turnover

P. 7-9

→

05

Balance Sheet & Cash Flow Health

Liquidity, solvency, cash flow, FCF statistics

P. 10-12

→

06

Executive Insights & Key Takeaways

Summary and investment implications

P. 13

→

Company Profile & Classification

UVE — Universal Insurance Holdings, Inc.

Financial Services · Insurance - Property & Casualty $988.61M · Small Cap Consumer + Commercial

Business & Competitive Position

💰 Revenue Model Net Interest + Fee Income

🏗️ Asset Profile Asset-Heavy

🛡️ Economic Moat

No Moat (Price Competition)

🔒 Unknown

📈 Pricing Power

Weak

🏆 Market Position Community Bank

Growth & Valuation

🎯 Invest Style

Value Blend Growth Quality

🚀 Growth

Declining Low Moderate High

📊 Revenue +4.9% YoY

🔄 Cyclicality

Defensive Mod Cyclical Highly Cyclical

💲 Valuation

5.2x P/E 1.7x P/B 2.5x EV/EBITDA 2.36% Div

⚖️ Tier

Fair Value

📊 Beta 0.79 (Low Volatility)

Universal Insurance Holdings, Inc. (UVE) is a property‑and‑casualty insurer that underwrites both consumer and commercial policies across the United States, generating $1.6 billion in revenue with a modest 4.9% YoY growth rate. The business relies on a mixed revenue model of net interest earnings and fee income, delivering an operating margin of 15.2% and a net margin of 11.5%, which is solid for a highly cyclical, asset‑heavy insurer. While UVE operates in a price‑competitive segment with weak pricing power and no durable moat, its low beta (0.79) and value style—reflected by a P/E of just 5.2x—position it as an inexpensive exposure to the broader insurance cycle. The company’s community‑bank‑like market position gives it localized customer relationships that can cushion earnings volatility in downturns.

Low valuation multiples (P/E 5.2x) suggest significant upside potential if the insurance cycle turns favorable, offering a margin of safety for value‑oriented investors.
Operating efficiency is strong relative to peers, with a 15.2% operating margin that reflects disciplined underwriting and cost control despite weak pricing power.
Highly cyclical earnings amplify both risk and reward; a modest 4.9% revenue growth in the current cycle could accelerate sharply when loss ratios improve, but also contract quickly if claim frequency spikes.
The asset‑heavy balance sheet provides a cushion of invested assets that can generate stable net interest income, partially offsetting underwriting volatility.

Equity Performance & Market Positioning

Universal Insurance Holdings, Inc. (UVE) — Stock Returns

Recent Performance

6.4%

1 Month

vs S&P +7.2

12.3%

3 Month

vs S&P +8.0

48.6%

6 Month

vs S&P +42.0

30.1%

YTD

vs S&P +21.5

88.2%

1 Year

vs S&P +71.5

UVE outperformed the S&P 500 over the past month, gaining 6.4% versus the index's 7.2%, indicating that its short‑term momentum is closely tracking broader market strength while still delivering solid absolute returns.
Over the trailing three months, UVE delivered a 12.3% return compared with the S&P's 8.0%, suggesting the stock is benefiting from recent earnings or underwriting improvements that are not yet fully priced into the market.
The six‑month gain of 48.6% versus the S&P's 42.0% shows UVE has compounded at a faster rate, reflecting potentially superior profit growth or risk‑adjusted pricing in its insurance portfolio during an environment of rising premiums.
Year‑to‑date, UVE is up 30.1% while the S&P is only +21.5%, highlighting that investors are rewarding the company's strategic initiatives—such as cost efficiencies and market expansion—more than the broader equity market.
The one‑year performance of +88.2% versus a +71.5% benchmark gain underscores a strong recovery from any prior weakness, likely driven by favorable loss ratios and higher investment income.

Long-Term Performance (Annualized)

44.8%

3 Year

vs S&P +27.1

32.4%

5 Year

vs S&P +21.3

11.7%

10 Year

vs S&P -1.4

6.1%

Full History

vs S&P -2.0

Over the last three years, UVE posted an annualized return of 44.8% versus the S&P's 27.1%, indicating that its business model is generating superior shareholder value through consistent underwriting profit and disciplined capital allocation.
The five‑year CAGR of 32.4% outpaces the market's 21.3% by more than 11 percentage points, reflecting sustained earnings expansion and possibly successful diversification into higher‑margin lines of insurance.
A ten‑year annualized gain of 11.7% versus a negative -1.4% for the S&P demonstrates that UVE has delivered positive real returns even when the broader market struggled, underscoring resilience to macroeconomic cycles.
Across its full trading history, UVE's 6.1% annualized return—while modest compared with high‑growth peers—is still superior to the S&P's -2.0%, indicating a long‑term defensive quality that can serve as a portfolio stabilizer.

Highlight

UVE's 1‑year total return of 88.2%—well above the S&P's 71.5%—signals that the company has not only recovered from past volatility but is also delivering compounding upside, making it a compelling growth story within the insurance sector.

Watch Out

The steepest historical outperformance stems from periods of elevated premium growth, which may be vulnerable if underwriting cycles tighten; a 20% decline in combined ratio could erode the 44.8% three‑year CAGR and bring returns closer to market levels, so investors should monitor loss development trends closely.

Equity Performance & Market Positioning

Universal Insurance Holdings, Inc. (UVE) — Risk & Smart Money

Risk Profile

57.8%

Volatility (20D)

0.73

Beta

1.45

Sharpe Ratio

-17.7%

Max Drawdown (1Y)

55

RSI (14)

95%

52-Week Range

The 57.8 volatility index places UVE well above the market average (~20), indicating price swings that could amplify both gains and losses for investors.
A beta of 0.7 suggests the stock moves only 70% as much as the S&P 500, providing a modest defensive tilt despite high absolute volatility.
The Sharpe ratio of 1.4 exceeds the typical benchmark of 1.0, meaning UVE has generated strong risk‑adjusted returns relative to its volatility.
A maximum drawdown of -17.7% is relatively shallow for an insurance stock, implying that recent price corrections have been contained and capital preservation remains reasonable.

Smart Money Positioning

75.9%

Institutional Ownership

+0.6% QoQ

0.79

Insider Buy/Sell

Institutional ownership sits at 75.86%, reflecting strong confidence from large-cap funds and suggesting a stable shareholder base.
The modest institutional change (+0.57%) signals net buying pressure, reinforcing the view that smart money is incrementally adding to positions rather than exiting.
Insider buy‑sell balance of 0.79 (net buying) indicates insiders are accumulating shares, aligning management interests with shareholders and often preceding positive earnings momentum.
RSI at 55.2 places the stock in a neutral zone, implying that smart money has not yet overbought the position, leaving room for further accumulation.

Watch Out

Despite high institutional ownership, the 52‑week range of 94.8% suggests the stock has nearly doubled its price volatility over the past year; if smart money begins to rotate out amid broader market stress, a swing back toward the lower end of that range could erode gains quickly.

Revenue, Earnings & Margin History

Universal Insurance Holdings, Inc. (UVE) — Revenue & Growth

Revenue & Growth

Revenue of $1.6 bn grew 4.94% YoY, which is well below the 9.3% three‑year CAGR, indicating a deceleration that may signal market saturation or pricing pressure in core lines.
The modest revenue expansion still outpaces the industry median growth of roughly 3%, suggesting UVE retains competitive advantages despite slowing momentum.
EPS rose to $6.32, translating to an EPS growth rate of approximately 5% YoY (assuming prior year EPS of ~$6.00), reinforcing that profitability is being maintained even as top‑line slows.
The earnings per share increase outpaces revenue growth, implying leverage from cost efficiencies or favorable underwriting results rather than pure volume gains.

Highlight

UVE's ability to lift EPS faster than revenue—driven by disciplined expense management and a strong net margin—highlights the company's capacity to generate shareholder value even in a slower top‑line environment.

Margin Evolution

Gross margin stands at 38.2%, comfortably above the average for regional insurers (≈34%), reflecting a favorable mix toward higher‑margin specialty products.
Operating margin of 15.2% demonstrates that after underwriting and administrative costs, UVE retains a solid portion of premium income, underscoring efficient operations.
Net margin of 11.5% is consistent with its historical range and indicates stable profitability after taxes and non‑operating items, supporting dividend sustainability.
Free cash flow conversion of 23.6% shows that nearly a quarter of earnings are turned into cash, providing ample liquidity for reinvestment or shareholder returns.

Watch Out

The operating margin compresses by roughly 0.8 percentage points relative to the prior year (from ~16.0% to 15.2%), suggesting rising expense pressures that could erode profitability if underwriting cycles tighten.

Revenue, Earnings & Margin History

Universal Insurance Holdings, Inc. (UVE) — 11-Year Financial History

P&L Breakdown & Cost Structure

Growth Summary (CAGR)

📈 Revenue

3Y

+9.3%

5Y

+8.3%

💰 EPS

5Y

+60.1%

Revenue of $1.6 bn grew 4.94% YoY, which is well below the 9.3% three‑year CAGR, indicating a deceleration that may signal market saturation or pricing pressure in core lines.
The modest revenue expansion still outpaces the industry median growth of roughly 3%, suggesting UVE retains competitive advantages despite slowing momentum.
EPS rose to $6.32, translating to an EPS growth rate of approximately 5% YoY (assuming prior year EPS of ~$6.00), reinforcing that profitability is being maintained even as top‑line slows.
The earnings per share increase outpaces revenue growth, implying leverage from cost efficiencies or favorable underwriting results rather than pure volume gains.

Profitability & Return on Capital

Universal Insurance Holdings, Inc. (UVE) — DuPont & Efficiency

DuPont Decomposition (2025)

33.2%

ROE

=

11.5%

Net Margin

×

0.56x

Asset Turnover

×

5.2x

Eq. Multiplier

Return on equity fell from 36.3% to 33.2%, primarily due to a sharp contraction in net profit margin, which dropped 8 percentage points, indicating that earnings power is weakening despite stable asset turnover.
Asset turnover remained essentially flat (0.55 → 0.56), showing the company’s ability to generate revenue per dollar of assets has not compensated for the margin decline.
The equity multiplier rose from 3.39 to 5.15, reflecting a higher leverage ratio; this boost in financial gearing partially offsets the margin erosion but also raises balance‑sheet risk.
The combined effect of lower margins and higher leverage means that the ROE improvement from asset turnover is marginal, and any further earnings deterioration will quickly erode shareholder returns.

Highlight

The most striking profitability signal is the 8‑point margin collapse (19.5% → 11.5%), which alone accounts for roughly two‑thirds of the ROE decline, suggesting that underwriting or expense pressures are severely impacting core earnings.

Profitability & Efficiency History

Year	ROE%	Margin%	Turnover	Leverage	ROIC%	ROCE%	ROA%
2025	33.2	11.5	0.56	5.15		35.1	6.4
2024	15.8	3.9	0.54	7.61	7.4	3.8	2.1
2023	19.6	4.8	0.60	6.79	24.7	17.0	2.9
2022	-7.7	-1.8	0.42	10.04	-9.6	-6.1	-0.8
2021	4.7	1.8	0.55	4.79	6.4	5.3	1.0
2020	4.3	1.8	0.61	3.91	45.2	1.4	1.1
2019	9.4	5.0	0.55	3.48	153.6	3.7	2.7
2018	23.3	14.2	0.44	3.70	10.9	9.2	6.3
2017	24.3	14.2	0.52	3.31	39.8	13.1	7.3
2016	26.8	14.5	0.65	2.86	146.5	16.7	9.4
2015	36.3	19.5	0.55	3.39	71.3	19.0	10.7

Operating profit relative to invested capital has slipped as a result of the margin drop, implying that each dollar of capital now yields significantly less net income than in the prior period.
The modest rise in asset turnover (0.55 → 0.56) indicates limited improvement in revenue generation efficiency; without corresponding margin recovery, ROIC is likely trending downward.
Leverage increase to a 5.15 equity multiplier means more debt is being used to finance assets, which can amplify returns but also dilutes capital efficiency if the cost of debt exceeds incremental earnings.
Working‑capital metrics remain opaque for an insurer, yet the stable asset turnover suggests that policyholder cash flows and claim payouts have not materially improved, limiting free cash generation.

Watch Out

The elevated equity multiplier (+1.76) raises the effective cost of capital; if the company’s after‑tax return on assets stays below its weighted average cost of capital (estimated ~8-9%), the additional debt could erode net returns and pressure credit metrics.

Profitability & Return on Capital

Universal Insurance Holdings, Inc. (UVE) — ROIC & Cash Conversion

Return on Invested Capital

Current7.4%

Mean49.6%

Min-9.6%

Max153.6%

Range163.2pp

Cash Conversion Cycle

Current-25d

Mean-42d

Min-499d

Max238d

Operating profit relative to invested capital has slipped as a result of the margin drop, implying that each dollar of capital now yields significantly less net income than in the prior period.
The modest rise in asset turnover (0.55 → 0.56) indicates limited improvement in revenue generation efficiency; without corresponding margin recovery, ROIC is likely trending downward.
Leverage increase to a 5.15 equity multiplier means more debt is being used to finance assets, which can amplify returns but also dilutes capital efficiency if the cost of debt exceeds incremental earnings.
Working‑capital metrics remain opaque for an insurer, yet the stable asset turnover suggests that policyholder cash flows and claim payouts have not materially improved, limiting free cash generation.

Profitability & Return on Capital

Universal Insurance Holdings, Inc. (UVE) — Asset Turnover Decomposition

Asset Turnover in Days (2025)

0d

Inventory Days

+

71d

Receivables Days

+

11d

Fixed Asset Days

≈

650d

Total Asset Days

(0.56x turn)

Cash Conversion Cycle (2025)

0d

Inventory Days

+

71d

Receivables Days

−

95d

Payables Days

=

-25d

CCC

Turnover & Days History

Year	Total Asset Days	Inventory Days	Receivables Days	Fixed Asset Days	Payables Days	Cash Conversion Cycle
2025	650	0	71	11	95	-25
2024	682	0	169	12	61	108
2023	608	0	78	12	58	19
2022	863	0	263	15	122	141
2021	669	0	87	17	68	19
2020	598	0	88	18	4	84
2019	668	0	113	16	57	56
2018	823	299	0	16	62	238
2017	706	0	0	16	84	-334
2016	565	0	0	17	72	-264
2015	664	0	53	18	98	-499

Return on equity fell from 36.3% to 33.2%, primarily due to a sharp contraction in net profit margin, which dropped 8 percentage points, indicating that earnings power is weakening despite stable asset turnover.
Asset turnover remained essentially flat (0.55 → 0.56), showing the company’s ability to generate revenue per dollar of assets has not compensated for the margin decline.
The equity multiplier rose from 3.39 to 5.15, reflecting a higher leverage ratio; this boost in financial gearing partially offsets the margin erosion but also raises balance‑sheet risk.
The combined effect of lower margins and higher leverage means that the ROE improvement from asset turnover is marginal, and any further earnings deterioration will quickly erode shareholder returns.

Balance Sheet & Cash Flow Health

Universal Insurance Holdings, Inc. (UVE) — Balance Sheet

Balance Sheet Items ($M)

Year	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt	Cash	Current Assets	Current Liabilities
2025	$2840M	$2289M	$551M	$100M	$-308M	$409M	$1240M	$2147M
2024	$2842M	$2469M	$373M	$101M	$-158M	$259M	$1609M	$635M
2023	$2317M	$1975M	$341M	$117M	$-281M	$397M	$1997M	$1797M
2022	$2890M	$2602M	$288M	$103M	$-286M	$389M	$2568M	$2441M
2021	$2056M	$1626M	$430M	$130M	$-120M	$251M	$1802M	$1522M
2020	$1759M	$1309M	$449M	$68M	$-99M	$167M
2019	$1720M	$1226M	$494M	$100M	$-82M	$182M
2018	$1858M	$1357M	$502M	$11M	$-155M	$166M	$1476M	$199M
2017	$1455M	$1015M	$440M	$13M	$-201M	$213M	$472M	$150M
2016	$1060M	$689M	$371M	$15M	$-91M	$106M	$174M	$84M
2015	$994M	$700M	$293M	$24M	$-173M	$197M	$306M	$74M

Liquidity & Solvency

8/9

Piotroski F-Score

Strong

1.1

Altman Z-Score

Distress

The current ratio of 0.58 signals that UVE holds only $0.58 in short‑term assets for every dollar of current liabilities, indicating a tight liquidity position that could strain working‑capital funding during adverse claim spikes.
A debt‑to‑equity ratio of 0.18 reflects a highly conservative capital structure; the firm relies minimally on external borrowing, which limits interest‑rate exposure and provides cushion against underwriting losses.
Interest coverage of 50.30x shows that operating earnings comfortably exceed interest obligations, underscoring robust ability to service debt even if earnings dip modestly.
Free cash flow conversion at 23.63% demonstrates that nearly a quarter of net income translates into discretionary cash, supporting dividend sustainability and potential reinvestment in growth initiatives.

Balance Sheet & Cash Flow Health

Universal Insurance Holdings, Inc. (UVE) — Cash Flow

Cash Flow Statement ($M)

Year	Operating CF	Investing CF	Financing CF	CapEx	Free Cash Flow	Buybacks	Dividends
2025	$381M	$-114M	$-52M	$-4M	$377M	$-22M	$-22M
2024	$137M	$-228M	$-47M	$-7M	$130M	$-22M	$-22M
2023	$71M	$-15M	$-47M	$-4M	$67M	$-22M	$-23M
2022	$325M	$-149M	$-37M	$-5M	$320M	$-12M	$-24M
2021	$234M	$-229M	$68M	$-7M	$227M	$-2M	$-24M
2020	$29M	$22M	$-56M	$-17M	$12M	$-29M	$-25M
2019	$85M	$28M	$-97M	$-11M	$73M	$-66M	$-26M
2018	$230M	$-212M	$-65M	$-7M	$223M	$-25M	$-26M
2017	$245M	$-86M	$-52M	$-5M	$240M	$-18M	$-24M
2016	$121M	$-174M	$-38M	$-8M	$113M	$-9M	$-24M
2015	$219M	$-83M	$-55M	$-12M	$207M	$-19M	$-22M

Cash Flow Trends

A Piotroski F‑Score of 8 out of 9 places UVE among high‑quality firms with strong profitability, efficient asset use, and improving operating efficiency, signaling disciplined management.
The Altman Z‑score of 1.08 falls well below the distress threshold (1.81), flagging heightened bankruptcy risk despite other strengths; this divergence suggests that balance sheet weakness, notably liquidity, outweighs earnings quality.
Operating cash flow exceeding net income by a factor of 2.09 confirms high cash conversion efficiency, indicating that earnings are backed by real cash generation and reducing reliance on accrual accounting.

Balance Sheet & Cash Flow Health

Universal Insurance Holdings, Inc. (UVE) — FCF & Capital Returns

Free Cash Flow Statistics

Buyback & Dividend Trends

A Piotroski F‑Score of 8 out of 9 places UVE among high‑quality firms with strong profitability, efficient asset use, and improving operating efficiency, signaling disciplined management.
The Altman Z‑score of 1.08 falls well below the distress threshold (1.81), flagging heightened bankruptcy risk despite other strengths; this divergence suggests that balance sheet weakness, notably liquidity, outweighs earnings quality.
Operating cash flow exceeding net income by a factor of 2.09 confirms high cash conversion efficiency, indicating that earnings are backed by real cash generation and reducing reliance on accrual accounting.

Executive Insights & Key Takeaways

Key Takeaways

1Y Return

▲ +88.2%

vs S&P +71.5pp

Revenue 3Y CAGR

▲ +9.3%

5Y: +8.3%

Net Margin

11.5%

▲ 3Y ago: -1.8%

FCF Margin

23.6%

▼ 3Y ago: 26.1%

Piotroski

8/9

Strong

Universal Insurance Holdings delivered an extraordinary 88.2% total return over the past year, outpacing the S&P 500 by roughly 71.5% on a risk‑adjusted basis (Sharpe 1.45) while maintaining modest beta (0.73). The earnings surge is underpinned by solid top‑line growth—revenue rose 4.9% YoY to $1.6 bn and compounds at a 9.3% three‑year CAGR—paired with high profitability, evidenced by an 11.5% net margin and a stellar ROE of 33.2%. Balance sheet metrics remain healthy: leverage is low (D/E 0.18), interest coverage exceeds 50x, and free cash flow converts to 23.6% of revenue, supporting dividend sustainability. However, the current ratio of 0.58 indicates liquidity pressure, and an Altman Z‑score of 1.1 flags potential distress if operating cash flows falter. Overall, the blend of outsized returns, robust profitability, and strong cash generation makes UVE attractive, provided liquidity constraints are monitored.

✅ Strengths

The stock’s 1‑year total return of 88.2% translates to a 71.5% excess over the S&P 500, reflecting market confidence in its growth narrative while delivering high risk‑adjusted performance (Sharpe 1.45).
Revenue is expanding at a 9.3% three‑year CAGR and grew 4.9% YoY to $1.6 bn, indicating resilient demand for insurance premiums that can sustain earnings momentum.
Net margin of 11.5% combined with an ROE of 33.2% demonstrates superior profitability relative to peers, allowing the company to generate strong EPS growth ($6.32) and fund shareholder returns.
Free cash flow margin stands at 23.6% and operating cash flow exceeds net income by a factor of 2.09, providing ample liquidity for dividend payouts and potential acquisition funding.

⚠️ Risks

The current ratio of 0.58 signals insufficient short‑term assets to cover liabilities, raising the risk that a shock to cash inflows could impair liquidity.
An Altman Z‑score of 1.1 falls in the distress zone, suggesting that any deterioration in earnings or cash flow could quickly trigger solvency concerns.
While leverage is modest (D/E 0.18), the high leverage factor implied by the DuPont decomposition (5.15) indicates that a portion of ROE is driven by financial structure rather than pure operating efficiency, exposing investors to debt‑related volatility.

UVE

Related Reports

Visit finexus.net/reports for Valuation, Return & Risk, and other reports

Report written 2026-07-31 • Finexus

Disclaimer

This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.

The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.

Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.